Quantitative analysis for Immunocore Holdings plc (IMCR) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (63.0) (grade B). 25 signals analyzed (21 differentiated alt-data).
IMCR stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $29.24 | $28.50 | $28.79 |
| 2026-05-08 | $30.65 | $29.51 | $29.58 |
| 2026-05-20 | $29.93 | $28.94 | $29.54 |
| 2026-06-02 | $29.73 | $28.04 | $29.56 |
| 2026-06-12 | $29.54 | $28.56 | $28.96 |
| 2026-06-25 | $31.57 | $29.75 | $30.54 |
| 2026-07-08 | $33.80 | $32.65 | $33.78 |
| 2026-07-20 | $35.00 | $33.99 | $34.05 |
| 2026-07-30 | $33.91 | $33.02 | $33.87 |
| 2026-08-12 | $34.87 | $34.13 | $34.74 |
| 2026-08-24 | $36.93 | $35.72 | $36.61 |
| 2026-09-03 | $37.66 | $36.70 | $37.57 |
How Immunocore Holdings plc stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| IMTX | Immatics N.V. | $1.5B | — |
| ATAI | Atai Beckley N.V | $1.5B | — |
| QURE | uniQure N.V. | $1.5B | 38.0 |
| GHRS | GH Research PLC | $1.5B | 38.0 |
View all Health Care stocks by valuation and signals →
Immunocore Holdings plc (IMCR) scores Buy (63.0), with no measured dimension below 51. Its highest are technicals at 88, competitive moat at 87, valuation at 72, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 88 |
| competitive moat | 87 |
| valuation | 72 |
| analyst consensus | 61 |
| earnings quality | 51 |
StoQuant analyzes 25 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Immunocore Holdings plc (IMCR): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/IMCR"><img src="https://stoquant.com/badge/IMCR.svg" alt="Immunocore Holdings plc (IMCR) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.